Meridian Bioscience (VIVO) Tops Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts VIVO Hot Sheet
Price: $5.89 +8.07%
Financial Fact:
Research and development: 3.76M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Financial Fact:
Research and development: 3.76M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Meridian Bioscience (NASDAQ: VIVO) reported Q1 EPS of $0.20, $0.03 better than the analyst estimate of $0.17. Revenue for the quarter came in at $51.5 million versus the consensus estimate of $53.1 million.
GUIDANCE:
Meridian Bioscience sees FY2019 EPS of $0.74-$0.76, versus the consensus of $0.76.
- Net revenues Flat-2% growth
For earnings history and earnings-related data on Meridian Bioscience (VIVO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Ennis (EBF) Reports In-Line Q1 EPS
- Morgan Stanley sees little room left in steel rally, cuts Cleveland-Cliffs rating
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
